PDCD1 and B-cell chronic lymphocytic leukemia: It is plausible that combination checkpoint inhibition may be able to bypass negative feedback and multiple inhibitory receptors as has been demonstrated using a CLL murine model with dual anti-PD-1 and LAG-3 blockade (180).